# Nalbuphine Hydrochloride

NDC: 0409-1465
Generic name: NALBUPHINE HYDROCHLORIDE
Labeler / Manufacturer: Hospira, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Marketing started: 20041231

FDA application: ANDA070916

## Active ingredients

- NALBUPHINE HYDROCHLORIDE: 20 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0409-1465"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0409-1465
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6025e8d4-5083-4c3a-58a0-050e7b0b6150